StockData
QuidelOrtho Corp logo

QuidelOrtho Corp (QDEL) stock

QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3063% below fair value
$9.87−0.34 (-3.33%)

Close on Nov 17, 2026Market cap $676.84MP/E –Yield –

QuidelOrtho enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

QuidelOrtho's enterprise value was $3.59B on Nov 11, 2026, against $4.42B a year earlier. Over the last 5 years it ranged from $3.14B to $8.53B, with a median of $4.95B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.59B-20.3%
2025Dec 31, 2025$4.50B-16.7%
2024Dec 31, 2024$5.40B-26.9%
2023Dec 29, 2023$7.39B-10.8%
2022Dec 30, 2022$8.29B+53.6%
2021Dec 31, 2021$5.40B–

More QuidelOrtho figures

See a number that looks wrong?